Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Obama Wants Comparative Effectiveness Institute; Is NICE A Good Model?

This article was originally published in The Gray Sheet

Executive Summary

Democratic presidential candidate Sen. Barack Obama has proposed a comparative effectiveness institute as part of his health care reform plan, but an independent analysis by the Lewin Group suggests that many physicians may not adopt the practices recommended by such a body

You may also be interested in...



Post-Election Industry Outlook: New User Fees, More Aggressive FDA

With a Democrat-controlled government led by President-elect Barack Obama poised to take control, industry experts have begun speculating on the future of device regulation and reimbursement

Post-Election Industry Outlook: New User Fees, More Aggressive FDA

With a Democrat-controlled government led by President-elect Barack Obama poised to take control, industry experts have begun speculating on the future of device regulation and reimbursement

Much Research, Little Action On Comparative Effectiveness

Efforts to create an expanded federal program to research the comparative effectiveness of health services got another nudge July 31 with the introduction of new legislation

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026698

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel